| Cyclophosphamide therapy for secondary amyloidosis in a patient with juvenile idiopathic arthritis unresponsive to tumor necrosis factor α inhibitor therapy |
|
Han, Sun Ae
(Division of Nephrology, Department of Internal Medicine, Chosun University Medical School)
Yoon, Young Min (Division of Nephrology, Department of Internal Medicine, Chosun University Medical School) Lee, Wan Soo (Division of Nephrology, Department of Internal Medicine, Chosun University Medical School) Kim, Yun Sung (Division of Rheumatology, Department of Internal Medicine, Chosun University Medical School) Shin, Byung Chul (Division of Nephrology, Department of Internal Medicine, Chosun University Medical School) Chung, Jong Hoon (Division of Nephrology, Department of Internal Medicine, Chosun University Medical School) Kim, Hyun Lee (Division of Nephrology, Department of Internal Medicine, Chosun University Medical School) |
| 1 | Celik AF, Altiparmak MR, Pamuk GE, Pamuk ON, Tabak F. Association of secondary amyloidosis with common variable immune deficiency and tuberculosis. Yonsei Med J 2005;46:847-850. DOI |
| 2 | Ernandez T, Mayadas TN. Immunoregulatory role of TNF-alpha in inflammatory kidney diseases. Kidney Int 2009;76:262-276. DOI |
| 3 | Nakamura T, Higashi S, Tomoda K, Tsukano M, Shono M. Effectiveness of etanercept vs. cyclophosphamide as treatment for patients with amyloid A amyloidosis secondary to rheumatoid arthritis. Rheumatology (Oxford) 2012;51:2064-2069. DOI |
| 4 | Abdallah E, Waked E. Incidence and clinical outcome of renal amyloidosis: a retrospective study. Saudi J Kidney Dis Transpl 2013;24:950-958. DOI |
| 5 | Okuda Y, Ohnishi M, Matoba K, et al. Comparison of the clinical utility of tocilizumab and anti-TNF therapy in AA amyloidosis complicating rheumatic disease. Mod Rheumatol 2014;24:137-143. DOI |
 |
Korea Institute of Science and Technology Information
Gwahangno, Yuseong-gu, Daejeon, 305-806, Korea TEL : +82-42-869-1752
Copyright (c) 2009 KISTI. All Rights Reserved. For more information mail to
webmaster
